Publication | Closed Access
1263P Tislelizumab + chemotherapy vs chemotherapy alone as first-line treatment for locally advanced/metastatic nonsquamous NSCLC
10
Citations
0
References
2020
Year
MedicineAdvanced/metastatic Nonsquamous NsclcImmune Checkpoint InhibitorFirst-line TreatmentPharmacotherapyCancer TreatmentOncologyRadiation OncologyLung Cancer
No additional data available for this publication yet. Check back later!